Daily Bulletin

New data independently confirms and extends laboratory findings and expands safety profile of ATH434-PR Newswire APAC

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
Cision

MELBOURNE, Australia and SAN FRANCISCO, Aug. 4, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") today announced that new clinical and experimental pharmacology data for its lead drug candidate ATH434 (formerly PBT434) has been selected for presentation at the 2020 International Congress of...

Read more: New data independently confirms and extends laboratory findings and expands safety profile of...

More Articles ...

  1. Tile™ and Skullcandy Create Most Advanced True Wireless Finding Experience-PR Newswire APAC
  2. Trade360 Announces New Trading Platform-PR Newswire APAC
  3. Alterity Releases Appendix 4C - Q4 FY20 Quarterly Cash Flow Report-PR Newswire APAC

Business News

The Impact of a Defence Lawyer in Sydney: Providing Expert Legal Representation & Protection of Your Rights

In Sydney, as in other major cities, the role of a defence lawyer is pivotal within the legal system. Defence lawyers are tasked with defending individuals and organisations accused of criminal acti...

Daily Bulletin - avatar Daily Bulletin

Starting Your Own Design Agency

Starting a design agency can be both a thrilling and challenging journey. While your creative skills may be second nature—whether that’s in graphic design, branding, web design, or UX/UI—the busines...

Daily Bulletin - avatar Daily Bulletin

Common Mistakes That Entrepreneurs Make (and Why They Can Derail Your Business)

Starting and running a business is no easy feat, even if you have exceptional training and experience. Fortunately, you can achieve your business goals by avoiding mistakes that can put your busines...

Daily Bulletin - avatar Daily Bulletin